Biblio Discovery — Demo Discovery Service

972 results

Showing 1–20 · 0.13 seconds · RSS

Journal

Journal of Pharmaceutical Policy and Practice

Scopus

ISSN 2052-3211 · Taylor & Francis Group · 972 articles in the index

  1. Journal Article

    Effectiveness of person-centred versus usual care in elderly patients: findings from a multicentre randomised controlled trial

    C. Rovira; M. Casanovas; E. Vizcaino et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background The person-centred care model involves a multidisciplinary team providing individualised health and social care aligned with patient preferences and health goals. Although some evidence supports its use in primary care, it remains under-evaluated. This study aimed to evaluate the…

  2. Journal Article

    Real-world effectiveness, safety, and quality of life of biosynthetic semaglutide in Pakistani adults with type 2 diabetes mellitus: a study protocol

    Muhammad Daoud Butt; Arshad Hussain; Siew Chin Ong

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Introduction Type 2 diabetes (T2D) is a critical public health crisis in Pakistan, which currently holds the highest age-standardised prevalence globally. While semaglutide significantly improves glycemic control and weight, high costs limit access to the innovator molecule in low – and…

  3. Journal Article

    Financial reimbursement incentives in the use of biosimilars for rheumatoid arthritis in Japan

    Hiroaki Mamiya; Toshiki Fukasawa; Koji Kawakami

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Biosimilars present a significant opportunity for cost savings. However, the uptake of biosimilars has been inconsistent across different regions and drugs, highlighting the need for effective policy interventions. This study aimed to investigate the impact of Japan's reimbursement…

  4. Journal Article

    Health technology assessment in Jordan: current landscape, challenges, and future roadmap

    Khawla Abu Hammour; Faris El-Dahiyat; Zaheer-Ud-Din Babar et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Health Technology Assessment (HTA) is increasingly recognised as an essential tool for directing decisions on health policy, particularly those concerning coverage, reimbursement, price and value, especially in nations aiming for Universal Health Coverage (UHC). Jordan is a middle-income…

  5. Journal Article

    Reforming pharmacy education in Japan: insights from the 2022 model core curriculum in a global context

    Kayoko Takeda Mamiya

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    In response to demographic changes, technological innovation, and the increasing complexity of healthcare, Japan revised its Model Core Curriculum (MCC) for pharmacy education in 2022 (hereafter, the 2022 MCC). This reform aims to develop pharmacists with lifelong competencies, the ability to…

  6. Journal Article

    The impact of mHealth interventions on medication adherence in breast cancer: a systematic review of randomized controlled trials

    Rabia Hussain; Bayan F. Ababneh; Zaheer-Ud-Din Babar

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Non-adherence to medication can reduce therapeutic effectiveness in breast cancer patients, thereby increasing the risk of disease progression or recurrence. This study aimed to systematically review the existing scientific literature on the impact of mHealth interventions on medication…

  7. Journal Article

    Protected learning time in community pharmacy and possibilities for upscaling: an exploratory study in Wales, UK

    Sophie Bartlett; Alison Bullock

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background The remit of pharmacists’ vital role in the healthcare system is expanding, and continuous professional development (CPD) of pharmacists is critical. While CPD is mandatory in the UK, a lack of protected learning time (PLT) hinders engagement, particularly in community pharmacies. In…

  8. Journal Article

    Economic evaluation of cyclin-dependent kinases 4 and 6 inhibitors in advanced hormonal receptor-positive and human epidermal growth factor receptor 2 negative breast cancer: a nationwide budget impact analysis

    Shereen Elazzazy; Nour Hisham Al-Ziftawi; Laila Shafei et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Several trials demonstrated improvements in clinical outcomes associated with cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors in breast cancer patients. The challenge remains regarding their high costs. Ribociclib and Abemaciclib are cost-effective in Qatar. Yet, their affordability…

  9. Journal Article

    Exploring consumer experiences of pharmacist prescribing – a scoping review

    Sheilpa Shivangani Sen; Bandana Saini; Betty Chaar

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Introduction The evolving scope of practice for pharmacists now encompasses a transition from traditional dispensing roles towards an integration of expanded clinical services, which include but are not limited to vaccinations, medication reviews, and prescribing. This scoping review aimed to…

  10. Journal Article

    Pharmacy professionals’ knowledge, attitudes, and behaviours regarding antibiotic use and antimicrobial resistance in Oman

    Zainab Said Al-Hashimy; Barbara R. Conway; Marwa Al Qasmi et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background This study evaluated pharmacy professionals’ knowledge, attitudes, and behaviours regarding antibiotic use and antimicrobial resistance (AMR) in Oman.Methods A cross-sectional, questionnaire-based survey was conducted among 411 pharmacy professionals in Ministry of Health (MOH)…

  11. Journal Article

    Advancing interprofessional collaboration: exploring physicians’ perceptions, preferences, and barriers regarding pharmacists’ roles in Jordan

    Zelal Kharaba; Karem H. Alzoubi; Mai Riziq et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Interprofessional collaboration is crucial for improving healthcare delivery and addressing workforce challenges. Physician-pharmacist collaboration enhances patient care, improves medication management and health outcomes. While patients’ perspectives have been studied, physicians’…

  12. Journal Article

    Rethinking assessment for practice readiness: policy implications of the OSCE–practice mismatch in Malaysia

    Athirah Bakhtiar; Angelina Lim; Li Ling Yeap et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Experiential learning is central to pharmacy education, yet the translation of clinical skills from simulated examinations to actual practice remains under-researched. This study utilised mystery shopping to evaluate how well clinical competencies transfer when students move from…

  13. Journal Article

    Health system governance and pharmaceutical policy in Australia and Qatar: a comparative overview of access, reform, and equity

    Dina Abushanab; Daoud Al-Badriyeh

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    This commentary contrasts the healthcare systems in Australia and Qatar, emphasising how each nation addresses shifting health policy priorities amid demographic pressures, financing reforms, and pharmaceutical challenges. Australia, with its established Medicare system and institutionalised Health…

  14. Journal Article

    Pharmaceutical registration, essential medicines, and registration depth in Sri Lanka: a longitudinal analysis, 1991–2025

    Manori Jayasinghe; Amanda Rush; Andrew Wilson

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Pharmaceutical registration determines which medicines may enter the market, yet its role in shaping pharmaceutical market structure in relation to essential medicines has received limited attention, particularly in low- and middle-income countries. This study examined how pharmaceutical…

  15. Journal Article

    In-hospital antimicrobial use and multidrug-resistant infections among COVID-19 patients in Northern Malaysia (COVAM): a multicentre study

    Kah Shuen Thong; Chii-Chii Chew; Meng Fei Cheah et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background During the COVID-19 pandemic, empirical antimicrobials were frequently prescribed despite low documented rates of bacterial and fungal co-infections. While early pandemic data exist, evidence evaluating antimicrobial consumption and multidrug-resistant organism (MDRO) dynamics during…

  16. Journal Article

    Cost-effectiveness and budget impact of Luspatercept in Thai adults with transfusion-dependent beta-thalassaemia: a multi-state Markov model based on national claims data

    Khachen Kongpakwattana; Peerapon Wong; Nattiya Teawtrakul et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Luspatercept is a first-in-class erythroid maturation agent that reduces transfusion burden in adults with transfusion-dependent beta-thalassaemia (TDT). However, its cost-effectiveness has not been evaluated in middle-income settings. This study aimed to evaluate the cost-effectiveness…

  17. Journal Article

    Determinants of community pharmacists’ intention to provide pharmacist-driven vaccination services in selected Arabic-speaking countries: a theory of planned behaviour-based structural equation modelling study

    Ammar A. Jairoun; Abeer M. Al-Ghananeem; Moyad Shahwan et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background Community pharmacists are increasingly recognised as accessible healthcare providers who can contribute to immunisation programmes and improve vaccine coverage. However, pharmacist-driven vaccination services remain underutilised in many Arabic-speaking countries, and factors influencing…

  18. Journal Article

    Antibiotic and antiviral prescribing patterns among hospitalised patients with COVID-19 pneumonia in Mongolia: a real-world descriptive retrospective study

    Narangarav Nyamdag; Nina Muratkhan; Munkhbat Sukhee et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background During the COVID-19 pandemic, Mongolia, like many low- and middle-income countries, faced major healthcare delivery challenges due to limited system readiness, resource constraints, geopolitical vulnerabilities, and prolonged border closures. These factors caused shortages of laboratory…

  19. Journal Article

    Regulatory evolution and service delivery models of telepharmacy in Thailand: a review of pandemic responses and future policy directions

    Patama Tapchaisri; Anuchai Theeraroungchaisri

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background The COVID-19 pandemic accelerated digital health adoption in Thailand, disrupting traditional healthcare delivery and prompting rapid pharmaceutical system reforms. Prior to 2020, telepharmacy was virtually non-existent due to strict regulations mandating in-person dispensing at licensed…

  20. Journal Article

    Integrated AHP-Delphi and Mini-HTA for selection of metabolic drugs in China’s national medical insurance catalog: a framework towards quantitative dynamic adjustment

    Jiajin Li; Tianxiao Huang; Yujie Sun et al.

    Journal of Pharmaceutical Policy and Practice, Vol. 19 No. 1 · 2026 · English · DOAJ Scopus

    Background China’s high burden of metabolic disease requires more systematic approaches to selecting medicines for inclusion in the National Medical Insurance Catalog. Existing processes face difficulties in quantitatively balancing clinical value, target population needs, pharmacoeconomic…